In a filing, Oruka Therapeutics Inc revealed its 10% Owner JANUS HENDERSON GROUP PLC acquired Company’s shares for reported $17067.0 on Aug 16 ’24. In the deal valued at $2.93 per share,5,818 shares were bought. As a result of this transaction, JANUS HENDERSON GROUP PLC now holds 2,117,213 shares worth roughly $44.74 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, JANUS HENDERSON GROUP PLC bought 189,856 shares, generating $606,873 in total proceeds. Upon buying the shares at $3.20, the 10% Owner now owns 2,081,168 shares.
Before that, JANUS HENDERSON GROUP PLC bought 30,227 shares. Oruka Therapeutics Inc shares valued at $92,292 were divested by the 10% Owner at a price of $3.05 per share. As a result of the transaction, JANUS HENDERSON GROUP PLC now holds 2,111,395 shares, worth roughly $44.61 million.
Stifel initiated its Oruka Therapeutics Inc [ORKA] rating to a Buy in a research note published on October 11, 2024; the price target was $49. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early October with a ‘”a Buy”‘ rating. Leerink Partners began covering ORKA with “an Outperform” recommendation on September 17, 2024. TD Cowen started covering the stock on September 16, 2024. It rated ORKA as “a Buy”.
Price Performance Review of ORKA
On Tuesday, Oruka Therapeutics Inc [NASDAQ:ORKA] saw its stock jump 0.62% to $21.13. Over the last five days, the stock has lost -5.88%. Oruka Therapeutics Inc shares have risen nearly 92.59% since the year began. Nevertheless, the stocks have risen 91.46% over the past one year. While a 52-week high of $33.00 was reached on 05/17/24, a 52-week low of $10.07 was recorded on 11/26/24. SMA at 50 days reached $24.44, while 200 days put it at $32.46.
Levels Of Support And Resistance For ORKA Stock
The 24-hour chart illustrates a support level at 20.53, which if violated will result in even more drops to 19.93. On the upside, there is a resistance level at 21.70. A further resistance level may holdings at 22.27. The Relative Strength Index (RSI) on the 14-day chart is 44.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.96, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.76%. Stochastics %K at 16.79% indicates the stock is a buying.
The most recent change occurred on September 13, 2024 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $40 price target.
